Clinical Trials Browser

Phase 1/2 × Unresectable Locally Advanced or Metastatic Solid Tumors × Etoposide × Clear all

NCT06682611 2024-11-12

Safety and Efficacy of SYHA1813 Single Agent or in Combination With Different Regimens in Unresectable Locally Advanced or Metastatic Solid Tumors.

Phase 1/2 Not yet recruiting

Other solid neoplasm

Unresectable Locally Advanced or Metastatic Solid Tumors